Literature DB >> 25404111

Cystic fibrosis genetics: from molecular understanding to clinical application.

Garry R Cutting1.   

Abstract

The availability of the human genome sequence and tools for interrogating individual genomes provide an unprecedented opportunity to apply genetics to medicine. Mendelian conditions, which are caused by dysfunction of a single gene, offer powerful examples that illustrate how genetics can provide insights into disease. Cystic fibrosis, one of the more common lethal autosomal recessive Mendelian disorders, is presented here as an example. Recent progress in elucidating disease mechanism and causes of phenotypic variation, as well as in the development of treatments, demonstrates that genetics continues to play an important part in cystic fibrosis research 25 years after the discovery of the disease-causing gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25404111      PMCID: PMC4364438          DOI: 10.1038/nrg3849

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  144 in total

1.  Recommendations for the classification of diseases as CFTR-related disorders.

Authors:  C Bombieri; M Claustres; K De Boeck; N Derichs; J Dodge; E Girodon; I Sermet; M Schwarz; M Tzetis; M Wilschanski; C Bareil; D Bilton; C Castellani; H Cuppens; G R Cutting; P Drevínek; P Farrell; J S Elborn; K Jarvi; B Kerem; E Kerem; M Knowles; M Macek; A Munck; D Radojkovic; M Seia; D N Sheppard; K W Southern; M Stuhrmann; E Tullis; J Zielenski; P F Pignatti; C Ferec
Journal:  J Cyst Fibros       Date:  2011-06       Impact factor: 5.482

2.  The silent codon change I507-ATC->ATT contributes to the severity of the ΔF508 CFTR channel dysfunction.

Authors:  Ahmed Lazrak; Lianwu Fu; Vedrana Bali; Rafal Bartoszewski; Andras Rab; Viktoria Havasi; Steve Keiles; John Kappes; Ranjit Kumar; Elliot Lefkowitz; Eric J Sorscher; Sadis Matalon; James F Collawn; Zsuzsanna Bebok
Journal:  FASEB J       Date:  2013-08-01       Impact factor: 5.191

3.  Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry.

Authors:  Todd MacKenzie; Alex H Gifford; Kathryn A Sabadosa; Hebe B Quinton; Emily A Knapp; Christopher H Goss; Bruce C Marshall
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

4.  Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.

Authors:  C S Chu; B C Trapnell; S M Curristin; G R Cutting; R G Crystal
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces.

Authors:  J-P Mornon; P Lehn; I Callebaut
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

6.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

8.  Mechanism-based corrector combination restores ΔF508-CFTR folding and function.

Authors:  Tsukasa Okiyoneda; Guido Veit; Johanna F Dekkers; Miklos Bagdany; Naoto Soya; Haijin Xu; Ariel Roldan; Alan S Verkman; Mark Kurth; Agnes Simon; Tamas Hegedus; Jeffrey M Beekman; Gergely L Lukacs
Journal:  Nat Chem Biol       Date:  2013-05-12       Impact factor: 15.040

9.  Genetic modifiers of liver disease in cystic fibrosis.

Authors:  Jaclyn R Bartlett; Kenneth J Friedman; Simon C Ling; Rhonda G Pace; Scott C Bell; Billy Bourke; Giuseppe Castaldo; Carlo Castellani; Marco Cipolli; Carla Colombo; John L Colombo; Dominique Debray; Adriana Fernandez; Florence Lacaille; Milan Macek; Marion Rowland; Francesco Salvatore; Christopher J Taylor; Claire Wainwright; Michael Wilschanski; Dana Zemková; William B Hannah; M James Phillips; Mary Corey; Julian Zielenski; Ruslan Dorfman; Yunfei Wang; Fei Zou; Lawrence M Silverman; Mitchell L Drumm; Fred A Wright; Ethan M Lange; Peter R Durie; Michael R Knowles
Journal:  JAMA       Date:  2009-09-09       Impact factor: 56.272

10.  Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia.

Authors:  Frauke Stanke; Tim Becker; Vinod Kumar; Silke Hedtfeld; Christian Becker; Harry Cuppens; Stephanie Tamm; Jennifer Yarden; Ulrike Laabs; Benny Siebert; Luis Fernandez; Milan Macek; Dragica Radojkovic; Manfred Ballmann; Joachim Greipel; Jean-Jacques Cassiman; Thomas F Wienker; Burkhard Tümmler
Journal:  J Med Genet       Date:  2010-09-12       Impact factor: 6.318

View more
  291 in total

1.  Cheat invasion causes bacterial trait loss in lung infections.

Authors:  Rolf Kümmerli
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-25       Impact factor: 11.205

2.  Efficient, non-toxic anion transport by synthetic carriers in cells and epithelia.

Authors:  Hongyu Li; Hennie Valkenier; Luke W Judd; Peter R Brotherhood; Sabir Hussain; James A Cooper; Ondřej Jurček; Hazel A Sparkes; David N Sheppard; Anthony P Davis
Journal:  Nat Chem       Date:  2015-11-02       Impact factor: 24.427

3.  Precision Medicine In Action: The Impact Of Ivacaftor On Cystic Fibrosis-Related Hospitalizations.

Authors:  Lisa B Feng; Scott D Grosse; Ridgely Fisk Green; Aliza K Fink; Gregory S Sawicki
Journal:  Health Aff (Millwood)       Date:  2018-05       Impact factor: 6.301

Review 4.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

5.  Gq activity- and β-arrestin-1 scaffolding-mediated ADGRG2/CFTR coupling are required for male fertility.

Authors:  Dao-Lai Zhang; Yu-Jing Sun; Ming-Liang Ma; Yi-Jing Wang; Hui Lin; Rui-Rui Li; Zong-Lai Liang; Yuan Gao; Zhao Yang; Dong-Fang He; Amy Lin; Hui Mo; Yu-Jing Lu; Meng-Jing Li; Wei Kong; Ka Young Chung; Fan Yi; Jian-Yuan Li; Ying-Ying Qin; Jingxin Li; Alex R B Thomsen; Alem W Kahsai; Zi-Jiang Chen; Zhi-Gang Xu; Mingyao Liu; Dali Li; Xiao Yu; Jin-Peng Sun
Journal:  Elife       Date:  2018-02-02       Impact factor: 8.140

Review 6.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

7.  Pharmacological Correction of Trafficking Defects in ATP-sensitive Potassium Channels Caused by Sulfonylurea Receptor 1 Mutations.

Authors:  Gregory M Martin; Emily A Rex; Prasanna Devaraneni; Jerod S Denton; Kara E Boodhansingh; Diva D DeLeon; Charles A Stanley; Show-Ling Shyng
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

8.  AC6 is the major adenylate cyclase forming a diarrheagenic protein complex with cystic fibrosis transmembrane conductance regulator in cholera.

Authors:  Andrew Thomas; Yashaswini Ramananda; KyuShik Mun; Anjaparavanda P Naren; Kavisha Arora
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

9.  Heritable disorders of connective tissue: Description of a data repository and initial cohort characterization.

Authors:  Rebecca Bascom; Jane R Schubart; Susan Mills; Thomas Smith; Linda M Zukley; Clair A Francomano; Nazli McDonnell
Journal:  Am J Med Genet A       Date:  2019-02-01       Impact factor: 2.802

10.  Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Authors:  Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.